SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...

From connectors and containers to plasmids and platforms, companies work to get these treatments to patients faster and more ...

President Trump is set to announce a trade deal with the UK Thursday, the first for his administration since imposing — then ...

Strategies to Remove Pre-Existing AAV Antibodies: IgG Enzymatic Degradation vs FcRn Inhibition. Presented by Yash Shah, PhD, ...

The relative valuations conducted in this article suggest that Cytek presents an undervaluation in the range of 16.43% to 109 ...

Experts set to speak at the NetZero Milan Expo-Summit 2025 on May 15 have told pv magazine that tunnel oxide passivated ...